Tubed or tubeless insulin pumps? A retrospective real-world analysis of national French health data
Hanaire H, Vimont A, Bonin A, et al.
BMJ Open Diabetes Res Care. Pub. online 30 Apr 2026.
Leggi
Associations of general adiposity, abdominal adiposity and their changes with fracture risk in chinese individuals with type 2 diabetes: a population-based cohort study in Hong Kong
Fan Y, Wu H, Lau ESH, et al.
Diabetes Care. Pub. online 30 Apr 2026.
Leggi
Elevated FIB-4 index as a risk marker within the KDIGO framework in patients with type 2 diabetes and hypertension
Fu H, Xing C, Wang H, et al.
BMJ Open Diabetes Res Care. Pub. online 28 Apr 2026.
Leggi
Pre-pregnancy GLP-1 receptor agonist or tirzepatide use and gestational diabetes risk: evaluating pharmacodynamic carry-over versus post-discontinuation metabolic rebound in a multinational federated cohort
Banerjee M, Dutta S, Dasgupta S
Diabetes Obes Metab. Pub. online 7 May 2026.
Leggi
GLP-1 receptor agonist therapy and cardiorenal outcomes in type 1 diabetes: a propensity-matched real-world analysis
Tentolouris A, Filippatos C, Tepetes NI, et al.
Diabetes Obes Metab. Pub. online 6 May 2026.
Leggi
Beyond GLP-1 monotherapy: novel multi-agonists, amylin analogues, and combination strategies in obesity and type 2 diabetes
Khachaturov M, Goulis DG
Diabetes Obes Metab. Pub. online 7 May 2026.
Leggi
WEBINAR ANNALI AMD 2026 – 26 MAGGIO
Carissimi Soci, dopo il successo della presentazione in anteprima dei nuovi dati Annali AMD alle Istituzioni, tenutasi il mercoledì scorso presso Palazzo Giustiniani – Senato della Repubblica, desideriamo ricordarvi il prossimo appuntamento dedicato a tutti i Soci AMD e alla diabetologia italiana per un approfondimento sulla raccolta 2025. Ci ritroveremo il 26 maggio alle ore 14.00…
Leggi
Expert considerations to guide the development and delivery of an exercise intervention in people with type 2 diabetes-related foot ulcer disease
Johnson VL, Hall V, Berrington R, et al.
Diabet Med. Pub. online 30 Apr 2026.
Leggi
Metformin: historical origins, mechanisms of action, and emerging clinical applications
Hu Y, Zhang X, Yang C, et al.
Diabetes Metab Res Rev. Pub. online 29 Apr 2026.
Leggi
Barriers and enablers to diabetes technologies use among individuals with type 1 diabetes: a scoping review
Palermo L, Senga J, Fakembe P, et al.
Diabetes Obes Metab. Pub. online 5 May 2026.
Leggi